Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In



Life Sciences

Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.

The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.

We have won a reputation for providing far-sighted advice to some of the world’s leading life science companies – including GlaxoSmithKline, Pfizer, UCB, Merck, Bayer and Novartis.

Recognition for our work

  • “Strong European offering with noted expertise in IP and patent litigation matters. Well regarded for its impressive client portfolio, which spans the pharmaceutical, biotechechnology, medtech, diagnostics and healthcare industries. Also offers impressive expertise in commercial transactions and M&A.”
    Chambers Global 2018 (Life Sciences: Global-wide)
  • “Fast and to-the-point advice and counselling”... “they have the understanding to adapt to what's needed.”
    Clients quoted in Chambers Europe 2017 (Life Sciences: Europe-wide) 
  • “The lawyers we worked with were uniformly excellent… it was great to work with a firm that had strong local counsel in several countries.”
    Client quoted in Chambers Europe 2017 (Intellectual Property: Europe-wide)

Find a lawyer

  • Expertise

  • Search Clear

An Insight in to our Life Science and Healthcare sector 2019


  • Add comment (optional)